Atorvastatin attenuates plaque vulnerability by downregulation of EMMPRIN expression via COX-2/PGE2 pathway

Authors

Keywords

Journal

Volume 13, Issue 3, Pages 835-844

Publisher

Spandidos Publications

Online

2017-01-19

DOI

10.3892/etm.2017.4062

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started